Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy

por A. V. Grigorieva, T. N. Iureva, Ju. V. Kursakova, E. I. Ivanova, D. Yu. Samsonov, I. M. Mikhalevich
Publicado 2021

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION

por S. A. Korotkikh, E. V. Bobykin, G. V. Zhiborkin, A. Y. Anashkin, A. V. Berezin
Publicado 2016

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age

por Karagiannis D, Kontadakis GA, Kaprinis K, Giarmoukakis A, Georgalas I, Parikakis EA, Tsilimbaris MK
Publicado 2017

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

por Tan CS, Sadda SR
Publicado 2017